Delivery Order SPE2DB24D3014-SPE2DB25FKUQL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,096.92. This competitively awarded, firm fixed-price delivery order is non-set-aside and is scheduled for completion by September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 18 mg capsules (30-count) on August 12, 2025, with a ceiling value of $1,569.60 and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery executed through AmerisourceBergen's existing contract vehicle with DLA. The place of performance is the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Atomoxetine HCL 40 mg capsules in quantities of 30 units. This contract represents a non-set-aside, competitively awarded delivery order with firm fixed pricing and a ceiling value of $1,996.53. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,265.16 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30. The contract utilizes firm fixed price pricing and carries an ultimate completion date of August 26, 2025. This non-set-aside competitive award will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Atomoxetine is a non-stimulant medication used primarily in the treatment of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a contract value of $1,935.72. This non-set-aside, competitively awarded delivery order represents a firm fixed-price transaction with an ultimate completion date of August 25, 2025. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine 18mg tablets (30-count units) under a firm fixed-price contract valued at $2,854.91, with completion targeted for August 26, 2025. This non-set-aside competitive award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $1,453.90 for the supply of Atomoxetine HCL 10 mg capsules (30-count units). This award, issued on July 31, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, to be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,281,057 units of Atomoxetine HCl 60 mg capsules. The delivery order is a firm-fixed price contract with a ceiling value of $1,022.40 and a period of performance through October 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a $179,450 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg Atomoxetine HCl capsules. As the prime contractor, Amerisourcebergen will deliver 30 capsules to an address in Conshohocken, Pennsylvania, fulfilling the contract within a day of the start date on August 1, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders under various...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUQLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine HCL 40 mg capsules (30-count) valued at $1,036.01, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its Pennsylvania location. This delivery order is a child contract issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Atomoxetine HCL—a medication used in attention and neurological treatment—exemplifies the range of pharmaceutical products the company provides through this strategic contract vehicle to support federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/10/25 |